N-Ethyl-4-Formyl-Benzeneacetamide: A Key Intermediate for Advanced Cancer Therapies
Unlock the potential of advanced cancer treatment with this vital pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value
N-Ethyl-4-Formyl-Benzeneacetamide
This chemical compound serves as a critical building block in the synthesis of Elacestrant, a breakthrough therapy targeting ESR1 mutations in advanced breast cancer. Its precise structure and quality are essential for ensuring the efficacy and safety of the final pharmaceutical product.
- Leveraging advanced pharmaceutical intermediate synthesis capabilities to produce high-quality N-Ethyl-4-Formyl-Benzeneacetamide.
- Meeting the stringent demands for Elacestrant intermediate chemical production in oncology drug development.
- Facilitating the journey from chemical synthesis to effective cancer treatment for ESR1 mutation breast cancer.
- Providing reliable chemical intermediates essential for API manufacturing in the pharmaceutical sector.
Product Advantages
Enhanced Efficacy
The precise manufacturing of this compound supports the development of Elacestrant, a drug with demonstrated efficacy in specific breast cancer subtypes, aiding in cancer treatment.
Quality Assurance
As a key component in Elacestrant synthesis, our commitment to quality ensures the reliability of this pharmaceutical intermediate for API manufacturing.
Targeted Application
This compound is specifically vital for producing Elacestrant, addressing the unmet needs in ESR1 mutation breast cancer treatment and advancing targeted therapies.
Key Applications
Pharmaceutical Synthesis
Used as a crucial building block in the complex chemical synthesis pathways required for modern pharmaceuticals, particularly for oncology drugs.
Oncology Drug Development
Essential intermediate for Elacestrant, a targeted therapy designed for patients with ESR1-mutated breast cancer, pushing the boundaries of cancer treatment.
Custom Synthesis
Available for custom synthesis projects, meeting the unique requirements of researchers and manufacturers in the pharmaceutical and biotech sectors.
Research and Development
Supports scientific research, enabling further exploration into new drug candidates and therapeutic mechanisms, contributing to ongoing advancements.